Details
Role
Honorary Fellow
Top Publications
-
Brown, LM, Huckstep, H, Sandow, J, Bartolo, RC, Davidson, N, Schmidt, B, Bjelosevic, S, Johnstone, RW, Oshlack, A, Davis, M, et al.
Different Classes of ABL1 Fusions Activate Different Downstream Signalling Nodes.
Blood
132(Supplement 1)
:
2628
2018
view publication
-
Khuong-Quang, D-A, Gayden, T, Sepulveda, F, Pratt, J, Valera, E, Garrigue, A, Kelso, S, Sicheri, F, Mikael, L, Hamel, N, et al.
Germline TIM-3 Mutations Characterize Sub-Cutaneous Panniculitis T-Cell Lymphomas with Hemophagocytic Lymphohistiocytic Syndrome.
Blood
132(Supplement 1)
:
1569
2018
view publication
-
Moujalled, DM, Hanna, DT, Pomilio, G, Litalien, V, Fleming, S, Chanrion, M, Maragno, A-L, Kraus-Berthier, L, Khaw, SL, Lessene, G, et al.
Identification of Potent BH3-Mimetic Combinations Targeting Pro-Survival Pathways in Human B-Cell Acute Lymphoblastic Leukemia.
Blood
132(Supplement 1)
:
567
2018
view publication
-
Salmon, JM, Pomilio, G, Moujalled, DM, Macraild, S, Teh, CE, Riajl, S, Ivey, A, Teh, T-C, Ekert, PG, Kraus-Berthier, L, et al.
Combined BCL-2 and HDAC Targeting Has Potent and TP53 Independent Activity in AML.
Blood
132(Supplement 1)
:
1426
2018
view publication
-
Ziegler, DS, Wong, M, Mayoh, C, Kumar, A, Tsoli, M, Mould, E, Tyrrell, V, Khuong-Quang, D-A, Pinese, M, Gayevskiy, V, et al.
Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma.
British Journal of Cancer
119(6)
:
693 -696
2018
view publication
